euro adhoc: Intercell AG / Joint Ventures/Cooperation/Collaboration / Intercell and Merck expand strategic alliance to develop prophylactic vaccine and antibody treatments against Group A Streptococcus
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 26.10.2006 » Agreement includes a USD 9.5 million upfront payment, up to USD 76 million milestone payments as well as royalties on future net sales of the product Intercell AG (VSE "ICLL") ...